» Authors » Mohamed H A Gadelmawla

Mohamed H A Gadelmawla

Explore the profile of Mohamed H A Gadelmawla including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 2
Citations 0
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alrashdi B, Askar H, Germoush M, Fouda M, Massoud D, Alzwain S, et al.
J Genet Eng Biotechnol . 2025 Mar; 23(1):100466. PMID: 40074440
Due to bleomycin's cytotoxic characteristics, which include cardiotoxicity, this investigation looked at the effectiveness of costus ethanolic extract in reducing cardiotoxicity in male rats receiving bleomycin therapy. Forty adult male...
2.
Alrashdi B, Askar H, Germoush M, Fouda M, Abdel-Farid I, Massoud D, et al.
Open Vet J . 2025 Feb; 14(12):3375-3387. PMID: 39927337
Background: Natural materials are frequently good options for drug development, regardless of their source. It has been demonstrated that curcumin boosts antioxidant capacity and guards against diabetic disorders. Aim: The...
3.
Abdel-Wahhab K, Ashry M, Hassan L, El-Azma M, Elqattan G, Gadelmawla M, et al.
Sci Rep . 2024 Sep; 14(1):21066. PMID: 39256408
This study aimed to estimate the hepatic and immune ameliorating potential of extracted bovine lactoferrin (LF), Selenium nanoparticles (SeNPs) or their combination (LF/SeNPs) against bleomycin (BLM) induced hepatic injury. Fifty...
4.
Arab H, Alsufyani S, Ashour A, Gad A, Elhemiely A, Gadelmawla M, et al.
Pharmaceuticals (Basel) . 2024 Jul; 17(7). PMID: 39065759
The reproductive system of males is adversely impacted by lead (Pb), a toxic heavy metal. The present study examined arbutin, a promising hydroquinone glycoside, for its potential ameliorative impact against...